FibroGen, Inc - Common Stock (NQ:FGEN)

9.710 UNCHANGED

Last Price Updated: 4:00 PM EST, Jan 7, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about FibroGen, Inc - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

FibroGen Inc (NASDAQ:FGEN) Stock Rises on Q3 2025 Earnings Beat and Strategic Updates ↗

November 10, 2025

FibroGen stock rose after a Q3 2025 earnings beat and the $220M sale of its China operations to AstraZeneca, boosting its financial position.

Via Chartmill

Topics Earnings

Fibrogen Gets Regulator’s Green Light To Sell China Unit To AstraZeneca ↗

August 18, 2025

Via Stocktwits

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

August 12, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

August 11, 2025

Via Benzinga

These stocks are moving in today's after hours session ↗

August 11, 2025

As the regular session of the US market on Monday comes to an end, let's delve into the after-hours session and discover the top gainers and losers shaping the post-market sentiment.

Via Chartmill

Uncovering Potential: FibroGen's Earnings Preview ↗

August 08, 2025

Via Benzinga

Earnings Scheduled For May 12, 2025 ↗

May 12, 2025

Via Benzinga

Beyond the Headlines: A Look at Today's Key Corporate Earnings Reports

August 11, 2025

Today, August 11, 2025, marks a significant day for investors looking beyond the typical S&P 500 giants, as a diverse array of companies across various sectors unveiled their latest quarterly earnings....

Via MarketMinute

Topics Economy Stocks

Stock Market Today: PROK Soars 515% on Surging Volume Amid Clinical Trial Buzz ↗

July 08, 2025

Via The Motley Fool

Topics Stocks

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

July 02, 2025

Via Benzinga

A Preview Of FibroGen's Earnings ↗

May 09, 2025

Via Benzinga

Earnings Scheduled For November 12, 2024 ↗

November 12, 2024

Via Benzinga

Earnings Outlook For FibroGen ↗

November 11, 2024

Via Benzinga

Earnings Scheduled For August 11, 2025 ↗

August 11, 2025

Via Benzinga

Adobe, FibroGen And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

June 13, 2025

Via Benzinga

Why RH Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket ↗

June 13, 2025

Via Benzinga

Adobe, RH And 3 Stocks To Watch Heading Into Friday ↗

June 12, 2025

Via Benzinga

Curious about the stocks that are showing activity after the closing bell on Thursday? ↗

June 12, 2025

Wondering what's happening in today's after-hours session? Stay tuned for the latest updates on stock movements.

Via Chartmill

12 Health Care Stocks Moving In Monday's After-Market Session ↗

June 02, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

March 19, 2025

Via Benzinga

Earnings Scheduled For March 17, 2025 ↗

March 17, 2025

Via Benzinga

What's going on in today's pre-market session ↗

February 25, 2025

Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session.

Via Chartmill

On Friday, there are stocks with unusual volume. Let's take a look. ↗

February 21, 2025

On Friday, there are stocks with unusual volume. Let's take a look.

Via Chartmill

What's going on in today's session ↗

February 20, 2025

Intrigued by the market activity one hour before the close of the markets on Thursday? Uncover the key winners and losers of today's session in our insightful analysis.

Via Chartmill

Thursday's session: most active stocks ↗

February 20, 2025

Curious about the most active stocks on Thursday? Find out which stocks are dominating the market action!

Via Chartmill

Top movers in Thursday's session ↗

February 20, 2025

Stay up-to-date with the latest market trends in the middle of the day on Thursday. Explore the top gainers and losers during today's session in our detailed report.

Via Chartmill

Amid Mounting Pressure In China, AstraZeneca Buys FibroGen's Chinese Unit For $160 Million ↗

February 20, 2025

FibroGen sells its China unit to AstraZeneca for $160 million, extending its cash runway into 2027 and advancing its CD46-targeting ADC and PET imaging agent.

Via Benzinga

Let's uncover which stocks are experiencing notable gaps during today's session. ↗

February 20, 2025

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

Stay updated with the stocks that are on the move in today's pre-market session. ↗

February 20, 2025

As we await the opening of the US market on Thursday, let's delve into the pre-market session and discover the top gainers and losers shaping the early market sentiment.

Via Chartmill

FGEN Stock Earnings: FibroGen Beats EPS, Beats Revenue for Q2 2024 ↗

August 06, 2024

FGEN stock results show that FibroGen beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.

Via InvestorPlace

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.